The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability

PHASE4TerminatedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

March 31, 2014

Conditions
AnemiaEnd Stage Renal Disease
Interventions
OTHER

Individualized Anemia Mangement Protocol

"Phase 1 (1-3 months): Develop individualized patient models and Anemia Management Protocols (AMP) while patients are receiving standard medical care.~Phase 2 (9 months): Individualized AMP study period. Phase 3 (9 months): Follow up period: return to standard-care AMP ."

Trial Locations (1)

01013

Chicopee Dialysis Center, Chicopee

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Western New England Renal & Transplant Associates, PC

OTHER

lead

Michael Germain

OTHER

NCT01975844 - The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability | Biotech Hunter | Biotech Hunter